Showing results (41-50 of 67) with videos related to
Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|September 11, 2008
Equivalence tests for shelf life and average drug content in stability studiesGemechis D Djira, Ludwig A Hothorn, Yi TsongStatistics in Medicine|March 11, 2003
Identifying effective and/or safe doses by stepwise confidence intervals for ratiosFrank Bretz, Ludwig A Hothorn, Jason C HsuBiotechnology Journal|October 22, 2009
Statistical aspects of design and validation of microtitre-plate-based linear and non-linear parallel in vitro bioassaysHanne Zimmermann, Daniel Gerhard, Theo Dingermann, et al.The Journal of Rheumatology|October 11, 2002
Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged ratsFrieder Bauss, Sigrid Lalla, Richard Endele, et al.The International Journal of Biostatistics|August 2, 2013
Are multiple contrast tests superior to the ANOVA?Frank Konietschke, Sandra Bösiger, Edgar Brunner, et al.Statistics in Medicine|October 12, 2005
Power and sample size computations in simultaneous tests for non-inferiority based on relative marginsGemechis Dilba, Frank Bretz, Ludwig A Hothorn, et al.Integrated Environmental Assessment and Management|January 18, 2026
The Role of Statistical Power in Context: Implications for Regulatory PracticesZhenglei Gao, Ludwig A Hothorn, Luke Settles, et al.Nature Plants|August 16, 2018
Publisher Correction: The SERK3 elongated allele defines a role for BIR ectodomains in brassinosteroid signallingUlrich Hohmann, Joël Nicolet, Andrea Moretti, et al.Molecular Ecology|July 18, 2006
Impact of Bt maize pollen (MON810) on lepidopteran larvae living on accompanying weedsAchim Gathmann, Ludger Wirooks, Ludwig A Hothorn, et al.Journal of Immunological Methods|March 4, 2015
Statistical approaches for the determination of cut points in anti-drug antibody bioassaysFrank Schaarschmidt, Matthias Hofmann, Thomas Jaki, et al.Pageof 7